Valdecoxib News and Research

RSS
Valdecoxib is a substance that is being studied as a treatment for pain and other side effects of cancer therapy. It belongs to the family of drugs called COX-2 inhibitors.
Pfizer provides information about its COX-2 product Bextra (valdecoxib)

Pfizer provides information about its COX-2 product Bextra (valdecoxib)

COX-2 agents have influenced the way physicians prescribe rheumatology medication

COX-2 agents have influenced the way physicians prescribe rheumatology medication

Canadian Rheumatology Association issues statement on Vioxx alternatives

Canadian Rheumatology Association issues statement on Vioxx alternatives

EMEA statement following withdrawal of Vioxx (rofecoxib)

EMEA statement following withdrawal of Vioxx (rofecoxib)